Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Entacapone Combined With Bevacizumab in Patients With Glioblastoma at First Recurrence Based on the MYOF/p-STAT3 Signaling Axis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

NCT07831187 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT07831187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Entacapone Combined With Bevacizumab in Patients With Glioblastoma at First Recurrence Based on the MYOF/p-STAT3 Signaling Axis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2029
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma